Home/Filings/4/0001209191-23-012401
4//SEC Filing

Leavitt Chase C. 4

Accession 0001209191-23-012401

CIK 0001260990other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 8:01 PM ET

Size

5.6 KB

Accession

0001209191-23-012401

Insider Transaction Report

Form 4
Period: 2023-02-21
Leavitt Chase C.
General Counsel/Secretary
Transactions
  • Award

    Stock Option

    2023-02-21+210,000210,000 total
    Exercise: $0.96Exp: 2033-02-21Common Stock (210,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the stock option vest on first anniversary of the date of grant, and the remaining shares subject to the option vest in 36 equal monthly installments, subject to the recipient's continued employment or service with the Issuer on each such date.

Issuer

Oncternal Therapeutics, Inc.

CIK 0001260990

Entity typeother

Related Parties

1
  • filerCIK 0001777467

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:01 PM ET
Size
5.6 KB